Shopping Cart 0
Cart Subtotal
AED 0

Cyclopharm Ltd (CYC) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Cyclopharm Ltd (CYC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine. The company's products include Technegas, a lung imaging device used to diagnose the presence of blood clots in the lungs; and positron emission tomography (PET) radiopharmaceuticals. The company is evaluating Technegas in new indications such as chronic obstructive pulmonary disease (COPD), Asthma and lung cancer. Cyclopharm operates a joint venture, Macquarie Medical Imaging, which provides diagnostic imaging services such as 3T MRI, CT, X-ray, ultrasound and positron emission tomography (PET) scanning. The company harnesses its Ultralute technology, which extends the life of Molybdenum-99 generators. It operates in Asia Pacific, Canada, Latin America, Europe and Germany. Cyclopharm is headquartered in New South Wales, Australia.

Cyclopharm Ltd Key Recent Developments

Dec 19,2018: Cyclopharm announces positive business and trading update

Aug 08,2018: Cyclopharm 2018 first half preliminary headline update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Cyclopharm Ltd-Key Facts

Cyclopharm Ltd-Key Employees

Cyclopharm Ltd-Key Employee Biographies

Cyclopharm Ltd-Key Operational Employees

Cyclopharm Ltd-Major Products and Services

Cyclopharm Ltd-History

Cyclopharm Ltd-Company Statement

Cyclopharm Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Cyclopharm Ltd-Business Description

Business Segment: Molecular Imaging

Overview

Performance

Business Segment: Technegas

Overview

Performance

Geographical Segment: Asia Pacific

Performance

Geographical Segment: Canada

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Other

Performance

R&D Overview

Cyclopharm Ltd-SWOT Analysis

SWOT Analysis-Overview

Cyclopharm Ltd-Strengths

Cyclopharm Ltd-Weaknesses

Cyclopharm Ltd-Opportunities

Cyclopharm Ltd-Threats

Cyclopharm Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cyclopharm Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Dec 19, 2018: Cyclopharm announces positive business and trading update

Aug 08, 2018: Cyclopharm 2018 first half preliminary headline update

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Cyclopharm Ltd, Performance Chart (2014-2018)

Cyclopharm Ltd, Ratio Charts

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Cyclopharm Ltd, Key Facts

Cyclopharm Ltd, Key Employees

Cyclopharm Ltd, Key Employee Biographies

Cyclopharm Ltd, Key Operational Employees

Cyclopharm Ltd, Major Products and Services

Cyclopharm Ltd, History

Cyclopharm Ltd, Subsidiaries

Cyclopharm Ltd, Joint Venture

Cyclopharm Ltd, Key Competitors

Cyclopharm Ltd, Ratios based on current share price

Cyclopharm Ltd, Annual Ratios

Cyclopharm Ltd, Annual Ratios (Cont...1)

Cyclopharm Ltd, Annual Ratios (Cont...2)

Cyclopharm Ltd, Interim Ratios

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cyclopharm Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Cyclopharm Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

PETNET Solutions Cleveland LLC

Optiscan Imaging Ltd

Kent Hospital

China Renji Medical Group Ltd

Company Profile

Company Profile Title

Cyclopharm Ltd (CYC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine. The company's products include Technegas, a lung imaging device used to diagnose the presence of blood clots in the lungs; and positron emission tomography (PET) radiopharmaceuticals. The company is evaluating Technegas in new indications such as chronic obstructive pulmonary disease (COPD), Asthma and lung cancer. Cyclopharm operates a joint venture, Macquarie Medical Imaging, which provides diagnostic imaging services such as 3T MRI, CT, X-ray, ultrasound and positron emission tomography (PET) scanning. The company harnesses its Ultralute technology, which extends the life of Molybdenum-99 generators. It operates in Asia Pacific, Canada, Latin America, Europe and Germany. Cyclopharm is headquartered in New South Wales, Australia.

Cyclopharm Ltd Key Recent Developments

Dec 19,2018: Cyclopharm announces positive business and trading update

Aug 08,2018: Cyclopharm 2018 first half preliminary headline update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Cyclopharm Ltd-Key Facts

Cyclopharm Ltd-Key Employees

Cyclopharm Ltd-Key Employee Biographies

Cyclopharm Ltd-Key Operational Employees

Cyclopharm Ltd-Major Products and Services

Cyclopharm Ltd-History

Cyclopharm Ltd-Company Statement

Cyclopharm Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Cyclopharm Ltd-Business Description

Business Segment: Molecular Imaging

Overview

Performance

Business Segment: Technegas

Overview

Performance

Geographical Segment: Asia Pacific

Performance

Geographical Segment: Canada

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Other

Performance

R&D Overview

Cyclopharm Ltd-SWOT Analysis

SWOT Analysis-Overview

Cyclopharm Ltd-Strengths

Cyclopharm Ltd-Weaknesses

Cyclopharm Ltd-Opportunities

Cyclopharm Ltd-Threats

Cyclopharm Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cyclopharm Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Dec 19, 2018: Cyclopharm announces positive business and trading update

Aug 08, 2018: Cyclopharm 2018 first half preliminary headline update

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Cyclopharm Ltd, Performance Chart (2014-2018)

Cyclopharm Ltd, Ratio Charts

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Cyclopharm Ltd, Key Facts

Cyclopharm Ltd, Key Employees

Cyclopharm Ltd, Key Employee Biographies

Cyclopharm Ltd, Key Operational Employees

Cyclopharm Ltd, Major Products and Services

Cyclopharm Ltd, History

Cyclopharm Ltd, Subsidiaries

Cyclopharm Ltd, Joint Venture

Cyclopharm Ltd, Key Competitors

Cyclopharm Ltd, Ratios based on current share price

Cyclopharm Ltd, Annual Ratios

Cyclopharm Ltd, Annual Ratios (Cont...1)

Cyclopharm Ltd, Annual Ratios (Cont...2)

Cyclopharm Ltd, Interim Ratios

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cyclopharm Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cyclopharm Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Cyclopharm Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

PETNET Solutions Cleveland LLC

Optiscan Imaging Ltd

Kent Hospital

China Renji Medical Group Ltd